Efficacy of Normobaric High-Flow Oxygen Therapy Combined with Low Molecular Weight Heparin in the Management of Fetal Growth Restriction: A Prospective Cohort Study.

Int J Womens Health · 2026 · PMC13092235 · PMID 42011170

Europe PMC DOI

hedged sentence

0.2130

closest p · 4.3× alpha

0.2130

boldest claim

The sentences

did not reach statistical significanceP = 0.213not close (p > 0.1)

While Group 3 demonstrated superior outcomes compared with Group 1 (standard care), the incremental benefit of adding NHFOT to LMWH (ie., Group 3 vs Group 2) did not reach statistical significance for most endpoints—including FGR cure rate (45.83% vs 32.43%, P = 0.213)—though numerical trends favored Group 3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.